{"id":"https://openalex.org/W2381653403","doi":null,"title":"Clinical Trials of Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Chronic Heart Failure","display_name":"Clinical Trials of Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Chronic Heart Failure","alternate_titles":[],"publication_year":2001,"publication_date":"2001-01-01","ids":{"openalex":"https://openalex.org/W2381653403","mag":"2381653403"},"language":"en","primary_location":{"id":"mag:2381653403","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=GLYZ200106017","pdf_url":null,"source":{"id":"https://openalex.org/S2764396500","display_name":"The Chinese Journal of Clinical Pharmacology","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4320800687","host_organization_name":"Chinese Pharmaceutical Association","host_organization_lineage":["https://openalex.org/P4320800687"],"host_organization_lineage_names":["Chinese Pharmaceutical Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The Chinese Journal of Clinical Pharmacology","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2381653403"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Ji Hye Min","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Ji Hye Min","raw_affiliation_strings":["-Chun,GENG Xiao-Fang, YIN Min-De"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"-Chun,GENG Xiao-Fang, YIN Min-De","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13381","display_name":"Heart rate and cardiovascular health","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9610000252723694},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chronic-heart-failure","display_name":"chronic heart failure","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.8180000185966492},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9390000104904175},{"id":"https://openalex.org/keywords/synergistic-effect","display_name":"synergistic effect","score":0.7990000247955322},{"id":"https://openalex.org/keywords/patient-tolerance","display_name":"patient tolerance","score":0.4169999957084656}],"concepts":[{"id":"https://openalex.org/C2910553456","wikidata":"https://www.wikidata.org/wiki/Q285044","display_name":"Angiotensin Receptor Blockers","level":4,"score":0.7662218809127808},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.7240040302276611},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.714924156665802},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7098909616470337},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6854321360588074},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6461631059646606},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.5254494547843933},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.437274307012558},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.43190357089042664},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.40135642886161804},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3491936922073364},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.15663278102874756},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.09796977043151855},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07643017172813416}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2381653403","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=GLYZ200106017","pdf_url":null,"source":{"id":"https://openalex.org/S2764396500","display_name":"The Chinese Journal of Clinical Pharmacology","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4320800687","host_organization_name":"Chinese Pharmaceutical Association","host_organization_lineage":["https://openalex.org/P4320800687"],"host_organization_lineage_names":["Chinese Pharmaceutical Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The Chinese Journal of Clinical Pharmacology","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2021557771","https://openalex.org/W4252460588","https://openalex.org/W1767975966","https://openalex.org/W2073210130","https://openalex.org/W2312588380","https://openalex.org/W1542603493","https://openalex.org/W2118626367","https://openalex.org/W172497096"],"abstract_inverted_index":{"Many":[0],"clinical":[1,51],"trials":[2],"have":[3],"confirmed":[4],"that":[5],"Angiotensin":[6,12],"Converting":[7],"Enzyme":[8],"(ACE)":[9],"inhibitors":[10],"and":[11],"\u2161(A":[13],"\u2161)":[14],"receptor":[15],"blockers":[16],"are":[17,25,45],"effective":[18],"for":[19],"chronic":[20],"heart":[21],"failure.":[22],"Their":[23],"effects":[24],"dose-dependent,":[26],"high":[27],"dose":[28],"is":[29],"better":[30],"than":[31],"low":[32],"dose.":[33],"The":[34],"combination":[35],"therapy":[36],"has":[37],"synergistic":[38],"effect.":[39],"Recommended":[40],"doses":[41,44],"or":[42],"target":[43],"suggested":[46],"according":[47],"to":[48],"patients'tokrability":[49],"in":[50],"practice.":[52]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2381653403","counts_by_year":[],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
